Keyphrases
Disease Course
100%
Apoptotic Markers
100%
Pediatric Immune Thrombocytopenia
100%
Chronic Immune Thrombocytopenia
100%
Immune Thrombocytopenia
66%
Working Diagnosis
66%
Patient Serum
50%
Platelets
33%
Chronic Patients
33%
Anti-apoptotic Proteins
33%
Phosphatidylserine Exposure
33%
Healthy Controls
16%
Incubation
16%
Apoptosis
16%
Blood Samples
16%
Treatment Initiation
16%
CD40
16%
Flow Cytometry
16%
Thrombocytopenia
16%
Pathophysiology
16%
Control Subjects
16%
Apoptosis Markers
16%
Newly Diagnosed
16%
Pediatric Patients
16%
Insulin-like Growth Factor 2 mRNA-binding Protein 2 (IGF2BP2)
16%
Mitochondrial Inner Membrane Potential
16%
Patient's Will
16%
Neuroscience
Platelet
100%
Phosphatidylserine
100%
Membrane Potential
50%
Flow Cytometry
50%
Inner Membrane
50%
BIM Protein
50%
Pharmacology, Toxicology and Pharmaceutical Science
Disease Course
100%
Idiopathic Thrombocytopenic Purpura
100%
Phosphatidylserine
14%
Flow Cytometry
7%
BIM Protein
7%
Pathophysiology
7%
Biochemistry, Genetics and Molecular Biology
Idiopathic Thrombocytopenic Purpura
100%
Platelet
14%
Phosphatidylserine
14%
IGFBP2
7%
Flow Cytometry
7%
Membrane Potential
7%
P21
7%
Immunology and Microbiology
Idiopathic Thrombocytopenic Purpura
100%
Platelet
14%
Inner Membrane
7%
Membrane Potential
7%